← Open Payments lookup

EUNICE RAMOS: Open Payments

NPI 1750997789 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,215 in 81 payments from 12 companies in 2025. Trend: 2023 $132 · 2024 $507 · 2025 $2,215

Food & beverage: $2,215
CompanyPaymentsAmount
ABBVIE INC.26$619
Otsuka America Pharmaceutical, Inc.12$348
Neurocrine BioSciences, Inc.7$341
Vanda Pharmaceuticals Inc.8$233
Alkermes, Inc.3$166
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$139
Almatica Pharma LLC9$135
Lundbeck LLC5$92
Supernus Pharmaceuticals, Inc.5$77
Takeda Pharmaceuticals U.S.A., Inc.2$33

Products named: VRAYLAR, REXULTI, INGREZZA, FANAPT, CAPLYTA, LOREEV XR, LYBALVI, Qelbree.

Industry payments across NJ — which companies pay providers there.